Stress and the epigenetic landscape: A link to the pathobiology of human diseases?

Nature Reviews Genetics

Volumn 11, Issue 11, 2010, Pages 806-812

  Johnstone, Sarah E ^a   Baylin, Stephen B ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRG1 PROTEIN; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 5; K RAS PROTEIN; KRUPPEL LIKE FACTOR 4; POLYCOMB GROUP PROTEIN;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CELL PROLIFERATION; CELL RENEWAL; CELL STRESS; CHROMATIN; CHRONIC STRESS; COLON POLYPOSIS; DIABETES MELLITUS; DNA METHYLATION; DNA STRAND BREAKAGE; EPIGENETICS; GENE CONTROL; GENE SILENCING; INFLAMMATION; INSULIN RESISTANCE; LOSS OF FUNCTION MUTATION; NEOPLASM; NEUROFIBRILLARY TANGLE; NEUROLOGIC DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN PROCESSING; REVIEW; VASCULAR SMOOTH MUSCLE; BIOLOGICAL MODEL; DISEASE; GENETIC EPIGENESIS; GENETICS; HUMAN; PATHOLOGY; PHYSIOLOGICAL STRESS; PHYSIOLOGY; PRECANCER;

CELL PROLIFERATION; DIABETES COMPLICATIONS; DISEASE; EPIGENESIS, GENETIC; HUMANS; MODELS, BIOLOGICAL; PRECANCEROUS CONDITIONS; STRESS, PHYSIOLOGICAL;

EID: 77958093579     PISSN: 14710056     EISSN: 14710064     Source Type: Journal    
DOI: 10.1038/nrg2881     Document Type: Review

References (95)

1. Beckman, J. A., Creager, M. A. & Libby, P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 287, 2570-2581 (2002).
2. Hotamisligil, G. S. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 140, 900-917 (2010).
3. Visconti, R. & Grieco, D. New insights on oxidative stress in cancer. Curr. Opin. Drug Discov. Devel. 12, 240-245 (2009).
4. Zawia, N. H., Lahiri, D. K. & Cardozo-Pelaez, F. Epigenetics, oxidative stress, and Alzheimer disease. Free Radic. Biol. Med. 46, 1241-1249 (2009).
5. Rossi, D. J., Jamieson, C. H. & Weissman, I. L Stems cells and the pathways to aging and cancer. Cell 132, 681-696 (2008).
6. Silva, H. & Conboy, I. Aging and stem cell renewal. StemBook 1-13 (2008).
7. Chambers, S. M. et al. Aging hematopoietic stem cells decline in function and exhibit epigenetic dysregulation. PLoS Biol. 5. e201 (2007).
8. Coussens, L. M. & Werb, Z. Inflammation and cancer. Nature 420, 860-867 (2002).
9. Bird, A. DNA methylation patterns and epigenetic memory. Genes Dev. 16, 6-21 (2002).
10. Kouzarides, T. Chromatin modifications and their function. Cell 128, 693-705 (2007).
11. Li, B., Carey, M. & Workman, J. L. The role of chromatin during transcription. Cell 128, 707-719 (2007).
12. Misteli, T. Beyond the sequence: cellular organization of genome function. Cell 128, 787-800 (2007).
13. Lister, R. et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462, 315-322 (2009).
14. Hawkins, R. D. et al. Distinct epigenomic landscapes of pluripotent and lineage-committed human cells. Cell Stem Cell 6, 479-491 (2010).
15. Esteller, M. Epigenetics in evolution and disease. Lancet 372, S90-S96 (2008).
16. Nelson, W. G., De Marzo, A. M., DeWeese, T. L. & Isaacs, W. B. The role of inflammation in the pathogenesis of prostate cancer. J. Urol. 172, S6-S12 (2004).
17. Pani, G., Galeotti, T & Chiarugi, P. Metastasis: cancer cell's escape from oxidative stress. Cancer Metastasis Rev. 29, 351-378 (2010).
18. Meng, X. & Riordan, N. H. Cancer is a functional repair tissue. Med. Hypotheses 66, 486-490 (2006)
19. Dvorak, H. F. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med. 315, 1650-1659 (1986).
20. Iliopoulos, D., Hirsch, H. A. & Struhl, K. An epigenetic switch involving NF-?B, Lin28, Let-7 microRNA, and IL6 links inflammation to cell transformation. Cell 139, 693-706 (2009).
21. Tlsty, T D. & Coussens, L. M. Tumor stroma and regulation of cancer development. Annu. Rev. Pathol. 1, 119-150 (2006).
22. Orimo, A. & Weinberg, R. A. Stromal fibroblasts in cancer: a novel tumor-promoting cell type. Cell Cycle 5, 1597-1601 (2006).
23. Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57-70 (2000).
24. Gidekel Friedlander, S. Y. et al. Context-dependent transformation of adult pancreatic cells by oncogenic K-Ras. Cancer Cell 16, 379-389 (2009).
25. Baylin, S. B. & Ohm, J. E. Epigenetic gene silencing in cancer\ a mechanism for early oncogenic pathway addiction? Nature Rev. Cancer 6, 107-116 (2006).
26. Feinberg, A. P., Ohlsson, R. & Henikoff, S. The epigenetic progenitor origin of human cancer. Nature Rev. Genet. 7, 21-33 (2006).
27. Lowe, S. W., Cepero, E. & Evan, G. Intrinsic tumour suppression. Nature 432, 307-315 (2004).
28. Barker, N. et al. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457, 608-611 (2009).
29. Baylin, S. B. Stem cells, cancer, and epigenetics. StemBook 1-14 (2009).
30. Issa, J. P. CpG-island methylation in aging and cancer. Curr. Top. Microbiol. Immunol. 249, 101-118 (2000).
31. Issa, J. P. et al. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nature Genet. 7, 536-540 (1994).
32. Gazin, C., Wajapeyee, N., Gobeil, S., Virbasius, C. M. & Green, M. R. An elaborate pathway required for Ras-mediated epigenetic silencing. Nature 449, 1073-1077 (2007).
33. Opavsky, R. et al. CpG island methylation in a mouse model of lymphoma is driven by the genetic configuration of tumor cells. PLoS Genet. 3, 1757-1769 (2007).
34. Weinstein, I. B. Cancer. Addiction to oncogenes\ the Achilles heal of cancer. Science 297, 63-64 (2002).
35. Widschwendter, M. et al. Epigenetic stem cell signature in cancer. Nature Genet. 39, 157-158 (2007).
36. Schlesinger, Y. et al. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nature Genet. 39, 232-236 (2007).
37. Ohm, J. E. & Baylin, S. B. Stem cell chromatin patterns: an instructive mechanism for DNA hypermethylation? Cell Cycle 6, 1040-1043 (2007).
38. Cedar, H. & Bergman, Y. Linking DNA methylation and histone modification: patterns and paradigms. Nature Rev. Genet. 10, 295-304 (2009).
39. Bernstein, B. E. et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125, 315-326 (2006).
40. Chi, A. S. & Bernstein, B. E. Developmental biology Pluripotent chromatin state. Science 323, 220-221 (2009).
41. Vire, E. et al. The Polycomb group protein EZH2 directly controls DNA methylation. Nature 439, 871-874 (2006).
42. Tiwari, V. K. et al. PcG proteins, DNA methylation, and gene repression by chromatin looping. PLoS Biol. 6, 2911-2927 (2008).
43. O'Hagan, H. M., Mohammad, H. P. & Baylin, S. B. Double strand breaks can initiate gene silencing and SIRT1-dependent onset of DNA methylation in an exogenous promoter CpG island. PLoS Genet. 4, e1000155 (2008).
44. Ben-Porath, I. et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nature Genet. 40, 499-507 (2008).
45. Wierda, R. J., Geutskens, S. B., Jukema, J. W., Quax, P. H. & van den Elsen, P. J. Epigenetics in atherosclerosis and inflammation. J. Cell. Mol. Med. 14, 1225-1240 (2010).
46. Hang, C. T et al. Chromatin regulation by Brg 1 underlies heart muscle development and disease. Nature 466, 62-67 (2010)
47. Victor, V. M. et al. Oxidative stress, endothelial dysfunction and atherosclerosis. Curr. Pharm. Des 15, 2988-3002 (2009).
48. Hansson, G. K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352, 1685-1695 (2005).
49. Turunen, M. P., Aavik, E. & Yla-Herttuala, S. Epigenetics and atherosclerosis. Biochim. Biophys. Acta 1790, 886-891 (2009).
50. Kim, J. et al. Epigenetic changes in estrogen receptor ß gene in atherosclerotic cardiovascular tissues and in vitro vascular senescence. Biochim. Biophys. Acta 1772, 72-80 (2007).
51. Yoshida, T., Gan, Q. & Owens, G. K. Kruppel-like factor 4, Elk-1, and histone deacetylases cooperatively suppress smooth muscle cell differentiation markers in response to oxidized phospholipids. Am. J. Physiol. Cell Physiol. 295, C1175-C1182 (2008).
52. Owens, G. K., Kumar, M. S. & Wamhoff, B. R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol. Rev. 84, 767-801 (2004).
53. Ying, A. K. et al. Methylation of the estrogen receptor-α gene promoter is selectively increased in proliferating human aortic smooth muscle cells. Cardiovasc. Res. 46, 172-179 (2000).
54. Kim, J. et al. Epigenetic changes in estrogen receptor ß gene in atherosclerotic cardiovascular tissues and in-vitro vascular senescence. Biochim. Biophys. Acta 1772, 72-80 (2007).
55. Villeneuve, L. M. & Natarajan, R. The role of epigenetics in the pathology of diabetic complications. Am. J. Physiol. Renal Physiol. 299, F14-F25 (2010).
56. Chauhan, V. & Chauhan, A. Oxidative stress in Alzheimer's disease. Pathophysiology 13, 195-208 (2006).
57. Chauhan, A. & Chauhan, V. Oxidative stress in autism. Pathophysiology 13, 171-181 (2006).
58. Morris, L. G., Veeriah, S. & Chan, T. A. Genetic determinants at the interface of cancer and neurodegenerative disease. Oncogene 29, 3453-3464 (2010).
59. Dulac, C. Brain function and chromatin plasticity. Nature 465, 728-735 (2010).
60. Abel, T. & Zukin, R. S. Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders. Curr. Opin. Pharmacol. 8, 57-64 (2008).
61. Urdinguio, R. G., Sanchez-Mut, J. V. & Esteller, M. Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies. Lancet Neurol. 8, 1056-1072 (2009).
62. Wang, L. W., Berry-Kravis, E. & Hagerman, R. J. Fragile X: leading the way for targeted treatments in autism. Neurotherapeutics 7, 264-274 (2010).
63. Amir, R. E. et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nature Genet. 23, 185-188 (1999).
64. Yasui, D. H. et al. Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes. Proc. Natl Acad. Sci. USA 104, 19416-19421 (2007).
65. Chahrour, M. et al. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 320, 1224-1229 (2008).
66. Schanen, N. C. Epigenetics of autism spectrum disorders. Hum. Mol. Genet. 15, R138-R150 (2006).
67. Nguyen, A., Rauch, T. A., Pfeifer, G. P. & Hu, V. W Global methylation profiling of lymphoblastoid cell lines reveals epigenetic contributions to autism spectrum disorders and a novel autism candidate gene, RORA, whose protein product is reduced in autistic brain. FASEB J. 24, 3036-3051 (2010).
68. Bonda, D. J. et al. Oxidative stress in Alzheimer disease: a possibility for prevention. Neuropharmacology 59, 290-294 (2010).
69. Guglielmotto, M., Giliberto, L., Tamagno, E. & Tabaton, M. Oxidative stress mediates the pathogenic effect of different Alzheimer's disease risk factors. Front. Aging Neurosci. 2, 3 (2010).
70. Marques, S. C., Oliveira, C. R., Outeiro, T. F. & Pereira, C. M. Alzheimer's disease: the quest to understand complexity. J. Alzheimers Dis. 21, 373-383 (2010).
71. Donmez, G., Wang, D., Cohen, D. E. & Guarente, L. SIRT1 suppresses ß-amyloid production by activating the α-secretase gene ADAM10. Cell 142, 320-332 (2010).
72. Miao, F. et al. Lymphocytes from patients with type 1 diabetes display a distinct profile of chromatin histone H3 lysine 9 dimethylation: an epigenetic study in diabetes. Diabetes 57, 3189-3198 (2008).
73. Broske, A. M. et al. DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction. Nature Genet. 41, 1207-1215 (2009).
74. Trowbridge, J. J., Snow, J. W., Kim, J. & Orkin, S. H. DNA methyltransferase 1 is essential for and uniquely regulates hematopoietic stem and progenitor cells. Cell Stem Cell 5, 442-449 (2009).
75. Sen, G. L., Reuter, J. A., Webster, D. E., Zhu, L. & Khavari, P. A. DNMT1 maintains progenitor function in self-renewing somatic tissue. Nature 463, 563-567.
76. Jankowski, J. A. et al. Molecular evolution of the metaplasia-dysplasia- adenocarcinoma sequence in the esophagus. Am. J. Pathol. 154, 965-973 (1999).
77. Bian, Y. S., Osterheld, M. C., Fontolliet, C., Bosman, F. T. & Benhattar, J. p 16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus. Gastroenterology 122, 1113-11121 (2002).
78. Eads, C. A. et al. Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res. 61, 3410-3418 (2001).
79. Belinsky, S. A. Gene-promoter hypermethylation as a biomarker in lung cancer. Nature Rev. Cancer 4, 707-717 (2004).
80. Ling, C. & Groop, L. Epigenetics: a molecular link between environmental factors and type 2 diabetes. Diabetes 58, 2718-2725 (2009).
81. Woo, M. & Patti, M. E. Diabetes risk begins in utero. Cell Metab. 8, 5-7 (2008).
82. Park, J. H., Stoffers, D. A., Nicholls, R. D. & Simmons, R. A. Development of type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of Pdx1. J. Clin. Invest 118, 2316-2324 (2008).
83. Steger, D. J. et al. Propagation of adipogenic signals through an epigenomic transition state. Genes Dev. 24, 1035-1044 (2010).
84. Lefterova, M. I. et al. PPARy and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale. Genes Dev. 22, 2941-2952 (2008).
85. Fujiki, K., Kano, F., Shiota, K. & Murata, M. Expression of the peroxisome proliferator activated receptor y gene is repressed by DNA methylation in visceral adipose tissue of mouse models of diabetes. BMC Biol. 7, 38 (2009).
86. Thorel, F. et al. Conversion of adult pancreatic α-cells to ß-cells after extreme ß-cell loss. Nature 464, 1149-1154 (2010).
87. Jones, P. A. et al. Moving AHEAD with an international human epigenome project. Nature 454, 711-715 (2008).
88. Feinberg, A. P. Genome-scale approaches to the epigenetics of common human disease. Virchows Arch. 456, 13-21 (2010).
89. O'Neill, L. P, VerMilyea, M. D. & Turner, B. M. Epigenetic characterization of the early embryo with a chromatin immunoprecipitation protocol applicable to small cell populations. Nature Genet. 38, 835-841 (2006).
90. Jones, P. A. & Baylin, S. B. The epigenomics of cancer. Cell 128, 683-692 (2007).
91. Egger, G., Liang, G., Aparicio, A. & Jones, P. A. Epigenetics in human disease and prospects for epigenetic therapy. Nature 429, 457-463 (2004).
92. Guy, J., Gan, J., Selfridge, J., Cobb, S. & Bird, A. Reversal of neurological defects in a mouse model of Rett syndrome. Science 315, 1143-1147 (2007).
93. Qin, W. et al. Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J. Biol. Chem. 281, 21745-21754 (2006).
94. Guarente, L. Cell biology. Hypoxic hookup. Science 324, 1281-1282 (2009).
95. Peleg, S. et al. Altered histone acetylation is associated with age-dependent memory impairment in mice. Science 328, 753-756 (2010).